STAT3-dependent transactivation of miRNA genes following Toxoplasma gondii infection in macrophage

Parasites and Vectors

Volumn 6, Issue 1, 2013, Pages

  Cai, Yihong ^a   Chen, He ^a   Jin, Lei ^b   You, Yibo ^c   Shen, Jilong ^a  

^a ANHUI MEDICAL UNIVERSITY   (China)

^b UNIVERSITY OF SYDNEY   (Australia)

^c UNIVERSITY OF SCIENCE AND TECHNOLOGY OF CHINA   (China)

Author keywords

Apoptosis; Macrophage; MicroRNA; STAT3; Toxoplasma

Indexed keywords

MICRORNA; MICRORNA 125B 2; MICRORNA 17-92; MICRORNA 23B 27B 24 1; MICRORNA 30C 1; STAT3 PROTEIN; UNCLASSIFIED DRUG;

APOPTOSIS; ARTICLE; BINDING SITE; CONTROLLED STUDY; FLOW CYTOMETRY; GENE CLUSTER; HOST CELL; HUMAN; HUMAN CELL; IN VITRO STUDY; MACROPHAGE; MICROARRAY ANALYSIS; PROMOTER REGION; PROTEIN BINDING; PROTEIN EXPRESSION; SIGNAL TRANSDUCTION; TOXOPLASMOSIS; TRANSACTIVATION; UPREGULATION;

ANIMALIA; TOXOPLASMA; TOXOPLASMA GONDII;

ANIMALS; GENE EXPRESSION REGULATION; MACROPHAGES; MICRORNAS; PROMOTER REGIONS, GENETIC; PROTEIN BINDING; STAT3 TRANSCRIPTION FACTOR; TOXOPLASMA;

EID: 84890256251     PISSN: None     EISSN: 17563305     Source Type: Journal    
DOI: 10.1186/1756-3305-6-356     Document Type: Article

References (34)

1. Anti-apoptotic effects of SERPIN B3 and B4 via STAT6 activation in macrophages after infection with Toxoplasma gondii. Song KJ, Ahn HJ, Nam HW, Korean J Parasitol 2012 50 1 6 10.3347/kjp.2012.50.1.1 22451727
2. Death receptor ligation or exposure to perforin trigger rapid egress of the intracellular parasite Toxoplasma gondii. Persson EK, Agnarson AM, Lambert H, Hitziger N, Yagita H, Chambers BJ, Barragan A, Grandien A, J Immunol 2007 179 8357 8365 18056381
3. Apoptosis and its modulation during infection with Toxoplasma gondii: molecular mechanisms and role in pathogenesis. Luder CG, Gross U, Curr Top Microbiol Immunol 2005 289 219 237 15791958 (Pubitemid 40283465)
4. Toxoplasma gondii infection confers resistance against BimS-induced apoptosis by preventing the activation and mitochondrial targeting of pro-apoptotic Bax. Hippe D, Weber A, Zhou L, Chang DC, Hacker G, Luder CG, J Cell Sci 2009 122 3511 3521 10.1242/jcs.050963 19737817
5. Toxoplasma co-opts host gene expression by injection of a polymorphic kinase homologue. Saeij JP, Coller S, Boyle JP, Jerome ME, White MW, Boothroyd JC, Nature 2007 445 324 327 10.1038/nature05395 17183270 (Pubitemid 46122820)
6. NF-kappaB p65-dependent transactivation of miRNA genes following Cryptosporidium parvum infection stimulates epithelial cell immune responses. Zhou R, Hu G, Liu J, Gong AY, Drescher KM, Chen XM, PLoS Pathog 2009 5 1000681 10.1371/journal.ppat.1000681 19997496
7. Mitochondria: releasing power for life and unleashing the machineries of death. Newmeyer DD, Ferguson-Miller S, Cell 2003 112 481 490 10.1016/S0092-8674(03)00116-8 12600312 (Pubitemid 36263081)
8. Microarray analysis reveals previously unknown changes in Toxoplasma gondii-infected human cells. Blader IJ, Manger ID, Boothroyd JC, J Biol Chem 2001 276 24223 24231 10.1074/jbc.M100951200 11294868
9. MicroRNAs: small RNAs with a big role in gene regulation. He L, Hannon GJ, Nat Rev Genet 2004 5 522 531 10.1038/nrg1379 15211354 (Pubitemid 38868508)
10. An artificial miRNA against HPSE suppresses melanoma invasion properties, correlating with a down-regulation of chemokines and MAPK phosphorylation. Liu X, Fang H, Chen H, Jiang X, Fang D, Wang Y, Zhu D, Plos one 2012 7 38659 10.1371/journal.pone.0038659 22719918
11. MicroRNA-149*, a p53-responsive microRNA, functions as an oncogenic regulator in human melanoma. Jin L, Hu WL, Jiang CC, Wang JX, Han CC, Chu P, Zhang LJ, Thorne RF, Wilmott J, Scolyer RA, et al. Proc Natl Acad Sci USA 2011 108 15840 15845 10.1073/pnas.1019312108 21896753
12. A single polymorphic amino acid on Toxoplasma gondii kinase ROP16 determines the direct and strain-specific activation of Stat3. Yamamoto M, Standley DM, Takashima S, Saiga H, Okuyama M, Kayama H, Kubo E, Ito H, Takaura M, Matsuda T, et al. J Exp Med 2009 206 2747 2760 10.1084/jem.20091703 19901082
13. Toxoplasma gondii rhoptry kinase ROP16 activates STAT3 and STAT6 resulting in cytokine inhibition and arginase-1-dependent growth control. Butcher BA, Fox BA, Rommereim LM, Kim SG, Maurer KJ, Yarovinsky F, Herbert DR, Bzik DJ, Denkers EY, PLoS Pathog 2011 7 1002236 10.1371/journal.ppat.1002236 21931552
14. Let-7 expression is a significant determinant of response to chemotherapy through the regulation of IL-6/STAT3 pathway in esophageal squamous cell carcinoma. Sugimura K, Miyata H, Tanaka K, Hamano R, Takahashi T, Kurokawa Y, Yamasaki M, Nakajima K, Takiguchi S, Mori M, Doki Y, Clin Cancer Res 2012 18 5144 5153 10.1158/1078-0432.CCR-12-0701 22847808
15. Inducible microRNA-223 down-regulation promotes TLR-triggered IL-6 and IL-1beta production in macrophages by targeting STAT3. Chen Q, Wang H, Liu Y, Song Y, Lai L, Han Q, Cao X, Wang Q, Plos one 2012 7 42971 10.1371/journal.pone. 0042971 22937006
16. microRNA-124 regulates cardiomyocyte differentiation of bone marrow-derived mesenchymal stem cells via targeting STAT3 signaling. Cai B, Li J, Wang J, Luo X, Ai J, Liu Y, Wang N, Liang H, Zhang M, Chen N, et al. Stem Cells 2012 30 1746 1755 10.1002/stem.1154 22696253
17. Genotypes and mouse virulence of Toxoplasma gondii isolates from animals and humans in China. Wang L, Chen H, Liu D, Huo X, Gao J, Song X, Xu X, Huang K, Liu W, Wang Y, et al. Plos one 2013 8 53483 10.1371/journal.pone.0053483 23308233
18. Genotyping of Toxoplasma gondii isolates from cats in different geographic regions of China. Chen ZW, Gao JM, Huo XX, Wang L, Yu L, Halm-Lai F, Xu YH, Song WJ, Hide G, Shen JL, Lun ZR, Vet Parasitol 2011 183 166 170 10.1016/j.vetpar.2011.06.013 21757292
19. 17-Beta-estradiol regulates expression of genes that function in macrophage activation and cholesterol homeostasis. Kramer PR, Wray S, J Steroid Biochem Mol Biol 2002 81 203 216 10.1016/S0960-0760(02)00065-1 12163132 (Pubitemid 34879931)
20. Interleukin-6 modulates the expression of the bone morphogenic protein receptor type II through a novel STAT3-microRNA cluster 17/92 pathway. Brock M, Trenkmann M, Gay RE, Michel BA, Gay S, Fischler M, Ulrich S, Speich R, Huber LC, Circ Res 2009 104 1184 1191 10.1161/CIRCRESAHA.109.197491 19390056
21. Synthetic miRNA-mowers targeting miR-183-96-182 cluster or miR-210 inhibit growth and migration and induce apoptosis in bladder cancer cells. Liu Y, Han Y, Zhang H, Nie L, Jiang Z, Fa P, Gui Y, Cai Z, Plos one 2012 7 52280 10.1371/journal.pone.0052280 23284967
22. Zhivotovsky B: miRNA-214 modulates radiotherapy response of non-small cell lung cancer cells through regulation of p38MAPK, apoptosis and senescence. Salim H, Akbar NS, Zong D, Vaculova AH, Lewensohn R, Moshfegh A, Viktorsson K, Br J Cancer 2012 107 1361 1373 10.1038/bjc.2012.382 22929890
23. Genomic analysis of human microRNA transcripts. Saini HK, Griffiths-Jones S, Enright AJ, Proc Natl Acad Sci U S A 2007 104 17719 17724 10.1073/pnas.0703890104 17965236 (Pubitemid 350210901)
24. Interleukin-6 dependent survival of multiple myeloma cells involves the Stat3-mediated induction of microRNA-21 through a highly conserved enhancer. Loffler D, Brocke-Heidrich K, Pfeifer G, Stocsits C, Hackermuller J, Kretzschmar AK, Burger R, Gramatzki M, Blumert C, Bauer K, et al. Blood 2007 110 1330 1333 10.1182/blood-2007-03-081133 17496199 (Pubitemid 47281433)
25. Widespread microRNA repression by Myc contributes to tumorigenesis. Chang TC, Yu D, Lee YS, Wentzel EA, Arking DE, West KM, Dang CV, Thomas-Tikhonenko A, Mendell JT, Nat Genet 2008 40 43 50 10.1038/ng.2007.30 18066065
26. Concomitant MYC and microRNA cluster miR-17-92 (C13orf25) amplification in human mantle cell lymphoma. Rinaldi A, Poretti G, Kwee I, Zucca E, Catapano CV, Tibiletti MG, Bertoni F, Leuk Lymphoma 2007 48 410 412 10.1080/ 10428190601059738 17325905 (Pubitemid 46994894)
27. MicroRNA control in the immune system: basic principles. Xiao C, Rajewsky K, Cell 2009 136 26 36 10.1016/j.cell.2008.12.027 19135886
28. miRiad roles for the miR-17-92 cluster in development and disease. Mendell JT, Cell 2008 133 217 222 10.1016/j.cell.2008.04.001 18423194 (Pubitemid 351508308)
29. Lower expression of inducible nitric oxide synthase and higher expression of arginase in rat alveolar macrophages are linked to their susceptibility to Toxoplasma gondii infection. Zhao ZJ, Zhang J, Wei J, Li Z, Wang T, Yi SQ, Shen JL, Yang TB, Hide G, Lun ZR, Plos one 2013 8 63650 10.1371/journal.pone.0063650 23691079
30. Differences in iNOS and arginase expression and activity in the macrophages of rats are responsible for the resistance against T. gondii infection. Li Z, Zhao ZJ, Zhu XQ, Ren QS, Nie FF, Gao JM, Gao XJ, Yang TB, Zhou WL, Shen JL, et al. Plos one 2012 7 35834 10.1371/journal.pone.0035834 22558235
31. Macrophages as a battleground for toxoplasma pathogenesis. Murray PJ, Cell Host Microbe 2011 9 445 447 10.1016/j.chom.2011.05.010 21669391
32. Identification and characterization of novel microRNAs from Schistosoma japonicum. Xue X, Sun J, Zhang Q, Wang Z, Huang Y, Pan W, Plos one 2008 3 4034 10.1371/journal.pone.0004034 19107204
33. Many roads to maturity: microRNA biogenesis pathways and their regulation. Winter J, Jung S, Keller S, Gregory RI, Diederichs S, Nat Cell Biol 2009 11 228 234 10.1038/ncb0309-228 19255566
34. Toxoplasma gondii infection specifically increases the levels of key host microRNAs. Michael T, Zeiner KLN J, Gusti M, et al. Plos one 2010 5 8742 e8750 10.1371/journal.pone.0008742 20090903